Self-renewal and solid tumor stem cells

University of Michigan Medical School, CCGC Room 4410, 1500 E Medical Center Drive, Ann Arbor 48109-0936, USA.
Oncogene (Impact Factor: 8.56). 10/2004; 23(43):7274-82. DOI: 10.1038/sj.onc.1207947
Source: PubMed

ABSTRACT Solid tumors arise in organs that contain stem cell populations. The tumors in these tissues consist of heterogeneous populations of cancer cells that differ markedly in their ability to proliferate and form new tumors. In both breast cancers and central nervous system tumors, cancer cells differ in their ability to form tumors. While the majority of the cancer cells have a limited ability to divide, a population of cancer stem cells that has the exclusive ability to extensively proliferate and form new tumors can be identified based on marker expression. Growing evidence suggests that pathways that regulate the self-renewal of normal stem cells are deregulated in cancer stem cells resulting in the continuous expansion of self-renewing cancer cells and tumor formation. This suggests that agents that target the defective self-renewal pathways in cancer cells might lead to improved outcomes in the treatment of these diseases.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The cancer stem cell (CSC) characterization represents a breakthrough in cancer research. Despite evidence showing the existence and the role of CSCs in osteosarcoma onset and progression, little is known about their specific surface phenotype. To address this issue we carried out a cytometric antibody-array analysis of 245 membrane proteins comparing the stem and differentiated osteosarcoma cells. As experimental model, we chose the stem-like cell line 3 AB-OS and its parental, differentiated cell line MG63. We identified 50 differentially expressed, 23 homogeneously expressed and 172 not expressed proteins in the two cell line models, thus defining a surface protein signature specific for each of them. Furthermore, we selected ERK1/2 (MAPK) as a potential pathway correlated with processes that characterize tumorigenic potential and stemness of 3AB-OS cells. This article is protected by copyright. All rights reserved.
    Proteomics 11/2013; 13(22). DOI:10.1002/pmic.201300170 · 3.97 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Cancer stem cells (CSCs) are a major cause of cancer treatment failure, relapse, and drug resistance and are known to be responsible for cancer cell invasion and metastasis. The Sonic hedgehog (Shh) signaling pathway is crucial to embryonic development. Intriguingly, the aberrant activation of the Shh pathway plays critical roles in developing CSCs and leads to angiogenesis, migration, invasion, and metastasis. Natural compounds and chemical structure modified derivatives from complementary and alternative medicine have received increasing attention as cancer chemopreventives, and their antitumor effects have been demonstrated both in vitro and in vivo. However, reports for their bioactivity against CSCs and specifically targeting Shh signaling remain limited. In this review, we summarize investigations of the compounds cyclopamine, curcumin, epigallocatechin-3-gallate, genistein, resveratrol, zerumbone, norcantharidin, and arsenic trioxide, with a focus on Shh signaling blockade. Given that Shh signaling antagonism has been clinically proven as effective strategy against CSCs, this review may be exploitable for development of novel anticancer agents from complementary and alternative medicine.
    Evidence-based Complementary and Alternative Medicine 05/2013; 2013:748587. DOI:10.1155/2013/748587 · 1.88 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Alkaline phosphatase (ALP) is known to be expressed in the several somatic stem cells and cancer cells. To investigate whether ALP may be a promising marker for cancer stem cells (CSCs), we examined the expression of ALP in human squamous cell carcinoma HeLa cells using a cytochemical staining kit. We found that approximately 40% of HeLa cells were positive for ALP activity. A single cell-derived colony assay revealed that the newly formed colonies could be classified into uniformly (U, 23%), mosaically (M, 17%), and non-stained (N, 60%) colonies. Each colony was picked and cultured for 2 additional weeks for cell propagation; the cells were either M- (45%) or N-type (55%), suggesting that the U-type colonies may have spontaneously changed to M-type colonies during cultivation. These resulting M- or N-type cells were stable with respect to ALP activity. DNA microarray analysis revealed that the gene expression pattern of N-type cells is almost identical to that of their parental HeLa cells (comprising M-type cells), but several genes including ALP gene were upregulated in the HeLa cells. Cultivation of single HeLa cell-derived colonies in the presence of the small molecule 6-bromoindirubin-3'-oxime (BIO), a potent inhibitor of glycogen synthase kinase 3 (GSK3), caused a reduction in the ratio of M-type colonies, suggesting that the transition from U- to M-type colonies is regulated by the Wnt/-catenin signaling pathway. Although there is no evidence, at present, that the ALP-positive cells are CSCs, future investigation may reveal that HeLa cells may be a good model for CSC study.
    03/2013; Article ID 208514:15. DOI:10.5171/2013.208514


1 Download
Available from